The judge deemed that J&J had declined to put resources toward advancing iPlatform and instead pitted it against its own Verb device.
J&J’s Ethicon completes first robot-assisted kidney stone removal with Monarch platform
Auris Health, an Ethicon subsidiary, received FDA clearance for Monarch for endourological procedures in May 2022.
Ethicon subsidiary of J&J holds onto most of robotic surgery patent in Intuitive Surgical challenge
Intuitive Surgical had challenged J&J’s Ethicon subsidiary on the combination of a shiftable drive system with a robotic surgery platform.
Verb Surgical debuts robot-assisted surgery prototype
Verb Surgical, Johnson & Johnson‘s (NYSE:JNJ) joint venture with Google parent Alphabet‘s (NSDQ:GOOGL) Verily Life Sciences, said today that it debuted its 1st digital surgery prototype to its collaboration partners at Ethicon Endo-Surgery and J&J. Robotic surgery, a fast growing field dominated by Intuitive Surgical (NSDQ:ISRG) and its da Vinci system, isn’t using robots yet, according to Verily CEO Andrew Conrad. In…